BIOMAT Database Logo BIOMAT Database Logo

Atrial natriuretic factor in patients on continuous ambulatory peritoneal dialysis. 1993

J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
Nephrology Service, Fundación Puigvert, Barcelona, Spain.

The aim of this study was to compare the levels of the atrial natriuretic factor (ANF) and the renin system in patients on continuous ambulatory peritoneal dialysis (CAPD) with patients on chronic hemodialysis (HD). We studied three groups. The CAPD group comprised 10 patients (25-66 years); the HD group: 10 patients (35-69 years), before (pre-HD) and after (post-HD) a HD session. The control group comprised 10 subjects with normal renal function (29-65 years), matched for age, height, weight, and diastolic pressure with the CAPD group. Blood pressure (BP) and blood samples for plasma renin activity (PRA), plasma aldosterone (PA), and ANF were taken. The BP and levels of ANF, PRA and PA were: in the control group, 121 +/- 15/75 +/- 4 mmHg, 7.3 +/- 5.6 pmol/L, 1.1 +/- 0.8 ng/mL/hour, 0.4 +/- 0.3 nmol/L. In the CAPD group, 132 +/- 26/76 +/- 12 mmHg (NS), 8.3 +/- 3.5 pmol/L (NS), 5.6 +/- 4.4 ng/mL/hour (p < 0.001), 4.9 +/- 4.0 nmol/L (p < 0.001). In the pre-HD, 159 +/- 25/95 +/- 12 mmHg (p < 0.001), 16.0 +/- 8.5 pmol/L (p < 0.005), 11.99 +/- 9.0 ng/mL/hour (p < 0.001), 2.6 +/- 2.3 nmol/L (p < 0.001). In the post-HD, 145 +/- 29/84 +/- 15 mmHg (p < 0.05 vs CG), 13.4 +/- 6.9 pmol/L (p < 0.05 vs control), 14.9 +/- 10.3 ng/mL/hour (p < 0.001 vs control), 3.8 +/- 2.9 nmol/L (p < 0.001 vs control).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
Plasma atrial natriuretic peptide levels in continuous ambulatory peritoneal dialysis patients.
January 1997, Nephron,
J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
January 1988, Nephron,
J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis.
October 2002, International journal of molecular medicine,
J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
Plasma levels of atrial natriuretic factor in normal children and patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
January 1993, Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,
J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
[Peritonitis in patients on continuous ambulatory peritoneal dialysis].
January 1996, Srpski arhiv za celokupno lekarstvo,
J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
Hyperlipidemia in continuous ambulatory peritoneal dialysis patients.
January 1993, ASAIO journal (American Society for Artificial Internal Organs : 1992),
J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
[Continuous ambulatory peritoneal dialysis in diabetic patients].
January 1998, Srpski arhiv za celokupno lekarstvo,
J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
Peritonitis in continuous ambulatory peritoneal dialysis patients.
May 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation,
J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
Continuous ambulatory peritoneal dialysis in diabetic patients.
January 1990, Contributions to nephrology,
J Mora-Maciá, and T Doñate, and J Ocón, and M Rodá, and G del Río
Tuberculous peritonitis in patients on continuous ambulatory peritoneal dialysis.
March 2000, The International journal of artificial organs,
Copied contents to your clipboard!